1MANCIA G, DEBACKER G, DOMINICZAK A, et al. 2007 Guidelines for the management of arterial hypertension : the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC) [J]. Eur Heart J, 2007,28(12) :1462 - 1536.
2MATCHAR D B, MCCRORY D C, ORLANDO L A, et al. Systematic review : comparative effectiveness of angiotensin- converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension [ J ]. Ann Intern Med, 2008,148(1) :16-29.
3SAWADA T, TAKAHASHI T, YAMADA H, et al. Rationale and design of the Kyoto Heart Study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events [J]. Journal of Human Hypertension, 2009, 23: 188- 195.
4MOCHIZUKI S, DAHLOF B, SHIMIZU M, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease ( Jikei Heart Study) : a randomised, open- label, blinded endpoint morbiditymortality study [ J]. Lancet,2007,369 : 1431 - 1439.
5ZHU J R, FUJITA T, SHIMAMOTO K, et al. Implication of clinical studies for the Asian population: focus on Chinese/Asian population[J]. J Clin Pract, 2006, 60 (Suppl 150) : 14 - 16.
6LINDHOLM L H, CARLBERG B, SAMUELSSON O. Shold β blockers remain first choice in the treatment of primary hypertension? a meta-analysis [ J ]. Lancet, 2005, 366 ( 9496 ) : 1545 - 1553.
7BANGALORE S, PARKAR S, GROSSMAN E, et al. A meta-analysis of 94 492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus [ J ]. Am J Cardiol, 2007, 100 ( 8 ) : 1254 - 1262.
8DAHLOF B, SEVER P S, POULTER N R, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a muhicentre randomised controlled trial [ J ]. Lancet,2005,366 (9489) : 895 - 906.
9WILLIAMS B, LACY P S, THOM S M, et al. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study [ J ]. Circulation, 2006,113 (9) : 1213 - 1225.
10O' ROURKE M F, SEWARD J B. Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov[J]. Mayo Clin Proc, 2006,81 (8) : 1057 - 1068.
